Global Biologics Contract Manufacturing Market to Reach US$29.03 Billion by 2030, Driven by Rising Chronic Diseases and Outsourcing Trends
The market of biologics encompasses pharmaceuticals derived from living cells or organisms, including proteins, antibodies, and gene therapies. In contrast to conventional medications created through …